Inspections, Compliance, Enforcement, and Criminal Investigations

Sabila SRL - Close Out Letter 10/17/13



Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
Washington, DC


October 17, 2013

Mr. Jaime A. Dajer
Sabila SRL
La Yuca, Cruce de Quinigua
Villa Gonzalez, Santiago 51601
Dominican Republic

Dear Mr. Dajer:

The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter #396438, issued July 1, 2013. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.




Robyn R. Jones
Compliance Officer
Office of Compliance
Center for Food Safety
and Applied Nutrition

Page Last Updated: 10/17/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English